Clinical Trials
3 trialsNCT04895748 2026-03-03
DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies
Novartis
Phase 1 Terminated
NCT04187404 2026-01-30
Spencer
Enterome
Phase 1/2 Terminated
NCT00911729 2013-06-10
Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
Molecular Insight Pharmaceuticals, Inc.
Terminated